Clinical Pharmacology and Approach to Dose Selection of Emestedastat, a Novel Tissue Cortisol Synthesis Inhibitor for the Treatment of Central Nervous System Disease.
Saved in:
| Title: | Clinical Pharmacology and Approach to Dose Selection of Emestedastat, a Novel Tissue Cortisol Synthesis Inhibitor for the Treatment of Central Nervous System Disease. |
|---|---|
| Authors: | Rolan, Paul1,2 (AUTHOR) paul.rolan@actinogen.com.au, Seckl, Jonathan3 (AUTHOR), Taylor, Jack1 (AUTHOR), Harrison, John4,5,6 (AUTHOR), Maruff, Paul7 (AUTHOR), Woodward, Michael8 (AUTHOR), Mills, Richard9 (AUTHOR), Jaros, Mark10 (AUTHOR), Hilt, Dana1 (AUTHOR) |
| Source: | Clinical Pharmacology in Drug Development. Feb2025, Vol. 14 Issue 2, p105-115. 11p. |
| Database: | Academic Search Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| ISSN: | 2160763X |
|---|---|
| DOI: | 10.1002/cpdd.1496 |
